×
About 6,863 results

ALLMedicine™ Hypokalemia Center

Research & Reviews  1,534 results

Burden and severity of deranged electrolytes and kidney function in children seen in a ...
https://doi.org/10.1371/journal.pone.0283220
PloS One; Obiagwu PN, Morrow B et. al.

Mar 18th, 2023 - Derangement in serum electrolytes and kidney function is often overlooked, especially in resource-constrained settings, and associated with increased risk of morbidity and mortality. This study aimed to describe the burden of derangements in serum...

Fanconi Syndrome Clinical Presentation
https://emedicine.medscape.com/article/981774-clinical

Mar 16th, 2023 - History The clinical features that cause patients to seek medical care include polyuria, polydipsia, bouts of dehydration (sometimes associated with fever), bone deformities, and impaired growth. Less often, the reasons for investigation are labor...

Hypokalemia
http://emedicine.medscape.com/article/242008-overview

Mar 13th, 2023 - Practice Essentials Hypokalemia is generally defined as a serum potassium level of less than 3.5 mEq/L (3.5 mmol/L). Moderate hypokalemia is a serum level of 2.5-3.0 mEq/L, and severe hypokalemia is a level of less than 2.5 mEq/L. [1] Hypokalemia ...

Hypokalemia Workup
http://emedicine.medscape.com/article/242008-workup

Mar 13th, 2023 - Approach Considerations Hypokalemia is defined as a condition in which the serum potassium level is less than 3.5 mEq/L (3.5 mmol/L). [50] By far the most common causes of hypokalemia are potassium losses caused by diuretics or gastrointestinal di...

Hypokalemia
https://emedicine.medscape.com/article/242008-print

Mar 13th, 2023 - Practice Essentials Hypokalemia is generally defined as a serum potassium level of less than 3.5 mEq/L (3.5 mmol/L). Moderate hypokalemia is a serum level of 2.5-3.0 mEq/L, and severe hypokalemia is a level of less than 2.5 mEq/L.[1] Hypokalemia i...

see more →

Guidelines  1 results

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an end...
https://doi.org/10.1210/jc.2008-0104
The Journal of Clinical Endocrinology and Metabolism; Funder JW, Carey RM et. al.

Jun 17th, 2008 - Our objective was to develop clinical practice guidelines for the diagnosis and treatment of patients with primary aldosteronism. The Task Force comprised a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society, si...

see more →

Drugs  707 results see all →

Clinicaltrials.gov  82 results

Preventing Metabolic Side Effects of Thiazide Diuretics With KMgCitrate
https://clinicaltrials.gov/ct2/show/NCT02665117

Feb 16th, 2023 - CTD- induced metabolic side effects were though to be dependent on hypokalemia, but subsequent studies suggested that CTD - induced side effects were independent from hypokalemia. On the other hand, magnesium depletion has been linked to increased...

Assessment of Trace Elements, Systemic Inflammation and Electrolytes
https://clinicaltrials.gov/ct2/show/NCT05718453

Feb 8th, 2023 - The most prominent features of COPD are systemic inflammation and oxidative stress. There is growing interest in establishing the significance of systemic inflammatory biomarkers in COPD patients, as they could be useful in evaluating exacerbation...

Comparison of a Low Dose to a Standard Dose of Insulin in Adult DKA in ICU to Reduce Metabolic Complications
https://clinicaltrials.gov/ct2/show/NCT05443802

Jan 23rd, 2023 - Diabetic ketoacidosis (DKA), a frequent complication of diabetes, is the consequence of a profound insulin deficiency responsible for osmotic polyuria which leads to major losses of water, sodium and potassium as well as the generation of metaboli...

Cardiac Arrhythmias at Extreme Altitude
https://clinicaltrials.gov/ct2/show/NCT05676398

Jan 18th, 2023 - Background: Several physiological changes at high altitude give rise to a pro-arrhythmic milieu. A fall in atmospheric pressure at high altitude decreases the partial pressure of oxygen (PaO2) and causes arterial hypoxemia. Respiratory alkalosis s...

Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study
https://clinicaltrials.gov/ct2/show/NCT04207203

Jan 18th, 2023 - Feasibility, descriptive single arm open-label interventional trial lasting 6 weeks. The study will recruit 36 CKD patients at the outpatient clinic with: age between 18 to 85 years; glomerular filtration rate < 29 ml/min/1.73 m2 and not on dialys...

see more →

News  417 results

Daily Thiazide No Help in Preventing Recurrent Kidney Stones
https://www.medpagetoday.com/nephrology/generalnephrology/103336

Mar 1st, 2023 - A common diuretic wasn't much help for staving off recurrent kidney stones, the NOSTONE trial showed. Over a median follow-up of 2.9 years, symptomatic or radiologic recurrence of kidney stones occurred in 59% of patients who received hydrochlorot...

Suicidality in an older patient with chronic kidney disease
https://www.mdedge.com/psychiatry/article/260354/depression/suicidality-older-patient-chronic-kidney-disease
Paul G. Yang, MS, Clark W. Johnson, MD et. al.

Dec 22nd, 2022 - CASE Depressed, anxious, and suicidal Mr. J, age 72, is brought to the emergency department by law enforcement at his wife’s request due to worsening suicidal thoughts and anxiety.

Cilta-cel Induces Strong Response in Chinese Patients With Relapsed/Refractory Multiple Myeloma
https://www.onclive.com/view/cilta-cel-induces-strong-response-in-chinese-patients-with-relapsed-refractory-multiple-myeloma

Nov 21st, 2022 - Ciltacabtagene autoleucel (cilta-cel; Carvykti) produced early, deep, and durable responses in patients with relapsed/refractory multiple myeloma (RRMM) treated at 8 sites in China.1 Investigators said the results from the pivotal phase 2 CARTIFAN...

FDA Approves Additional Dosing Schedule for Rylaze in ALL and LBL
https://www.onclive.com/view/fda-approves-additional-intramuscular-dosing-schedule-for-rylaze-in-all-and-lbl

Nov 18th, 2022 - The FDA has approved a supplemental biologics license application to add a Monday/Wednesday/Friday (MWF) intramuscular dosing schedule for asparaginase erwinia chrysanthemi (recombinant)-rywn (Rylaze).1 In June 2021, Rylaze was approved for use a...

Electrolyte Disturbances a Harbinger of Eating Disorders?
https://www.medscape.com/viewarticle/984087

Nov 15th, 2022 - Electrolyte abnormalities may serve as a precursor to a future eating disorder diagnosis, a finding that may help pinpoint candidates for screening. Researchers found that adolescents and adults with electrolyte abnormalities on routine outpatient...

see more →

Patient Education  4 results see all →